Wasada T, Sakimoto T, Aso Y, Kato K, Ibayashi H, Omori Y
Endocrinol Jpn. 1979 Feb;26(1):19-26. doi: 10.1507/endocrj1954.26.19.
A case of a 19-year-old, non-obese female with insulin resistant diabetes mellitus and polycystic ovary syndrome was reported. The maximal insulin requirement attained 360 units per day, but a satisfactory control of diabetes did not follow. The patient's serum contained not only anti-insulin antibodies, but also possible anti-insulin receptor antibodies which were demonstrated by the 125I-insulin binding test using insulin receptors derived from human placental plasma membrane. The insulin resistance in this case was assumed to be caused primarily by possible blocking antibodies to insulin receptors and partly by anti-insulin antibodies because of the following observations. First, high serum free insulin (165 microunits/ml) without hypoglycemia indicates the presence of insulin resistance due to other factors than antiinsulin antibodies. Second, the titer of 125I-insulin binding capacity of serum was not unusually higher than those seen in chronically insulin-treated diabetics. Third, immunologically heterospecies insulin (fish insulin) was also ineffective. The clinical features such as absence of ketoacidosis and association with polycystic ovary syndrome resemble those of an unique diabetic syndrome reported previously though acanthosis nigricans and endogenous hyperinsulinemia were not found in this case. Her insulin resistance remitted spontaneously and over the next 18 months' observation, her diabetes remained regulated without insulin therapy.
报告了一例19岁非肥胖女性,患有胰岛素抵抗型糖尿病和多囊卵巢综合征。其每日最大胰岛素需求量达到360单位,但糖尿病并未得到满意控制。患者血清中不仅含有抗胰岛素抗体,还可能含有抗胰岛素受体抗体,这通过使用源自人胎盘质膜的胰岛素受体进行的125I胰岛素结合试验得以证实。基于以下观察结果,该病例中的胰岛素抵抗被认为主要由可能的胰岛素受体阻断抗体引起,部分由抗胰岛素抗体引起。首先,高血清游离胰岛素(165微单位/毫升)且无低血糖表明存在除抗胰岛素抗体之外其他因素导致的胰岛素抵抗。其次,血清125I胰岛素结合能力的滴度并不比长期接受胰岛素治疗的糖尿病患者异常高。第三,免疫异源胰岛素(鱼胰岛素)也无效。尽管该病例未发现黑棘皮病和内源性高胰岛素血症,但诸如无酮症酸中毒以及与多囊卵巢综合征相关等临床特征与先前报道的一种独特糖尿病综合征相似。她的胰岛素抵抗自发缓解,在接下来18个月的观察期内,她的糖尿病在未接受胰岛素治疗的情况下仍得到控制。